Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mg
Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the bioequivalence of Mylan's metformin
hydrochloride ER tablets to Bristol-Myers Squibb's Glucophage® XR tablets following a single,
oral 500 mg (1 x 500 mg) dose administered under fed conditions.